top stories

BREAK­ING: Math­ai Mam­men makes an abrupt ex­it as head of the big R&D group at J&J

5 hours ago
R&D

No­vavax shares shred­ded as Covid vac­cine sales fall more than 90% in Q2

5 hours ago
Pharma

De­spite falling Covid-19 sales, BioN­Tech main­tains '22 sales guid­ance

10 hours ago
Pharma

In $1.36B biobuck deal with GSK, Mer­sana touts 'biggest pre­clin­i­cal ADC deal ever'

9 hours ago
Deals
Pharma

Latest

Most read

Up­dat­ed: Pfiz­er scoops up Glob­al Blood Ther­a­peu­tics and its sick­le cell ther­a­pies for $5.4B

18 hours ago
Deals

With drug pric­ing al­most done, Con­gress looks to wrap up FDA user fee leg­is­la­tion

11 hours ago
FDA+
Law

GSK and IQVIA launch plat­form of US vac­ci­na­tion da­ta, show­ing drop in adult rates

11 hours ago
Pharma

Ab­b­Vie sur­veys emo­tion­al im­pact of chron­ic leukemia con­di­tion, finds 'roller coast­er' of emo­tions

11 hours ago
Pharma
Marketing

As­traZeneca and Dai­ichi Sankyo sprint to mar­ket af­ter FDA clears En­her­tu in just two weeks

11 hours ago
Pharma
FDA+

FDA's vac­cine ad­comm to re­view first fe­cal trans­plant to treat C. dif­fi­cile in­fec­tions

12 hours ago
Pharma
FDA+
see latest stream
People

Q&A: Astel­las' re­tir­ing head of de­vel­op­ment re­flects on gene ther­a­py deaths

14 hours ago

Eli Lil­ly eyes growth out­side In­di­ana in wake of new abor­tion law — and New Jer­sey is ready

16 hours ago

Two years af­ter step­ping down amidst house ar­rest, Frank Zhang is back as Leg­end chair

3 days ago
Financing

With SPAC­s' high tide long gone, Blue Wa­ter ditch­es sec­ond blank check voy­age

4 days ago

Sofinno­va, For­bion back $70M push across fin­ish line for rare an­ti­fun­gal treat­ment

4 days ago

Days af­ter an FDA ap­proval for its pso­ri­a­sis drug, Ar­cutis looks to raise $150M in pub­lic cap­i­tal

5 days ago
Startups

David Hal­lal's El­e­vate­Bio launch­es new com­pa­ny to 'dis­rup­t' off-the-shelf cell ther­a­py, but pro­vides few oth­er ...

4 days ago

French biotech armed with Se­ries A looks to build out man­u­fac­tur­ing fa­cil­i­ty for plant-based pro­tein tech

6 days ago

New biotech from Alex­is Borisy will test Mer­ck KGaA, Blue­print can­cer drug com­bo in bid to ful­fill Gleevec promise

6 days ago
Deals

Sarep­ta li­cens­es next-gen AAV tech from Broad In­sti­tute in deal cov­er­ing five in­di­ca­tions — in­clud­ing Duchenne

14 hours ago

Break­ing: Pfiz­er in hot pur­suit of a $5B buy­out of Glob­al Blood Ther­a­peu­tics — re­port

3 days ago

Sanofi fronts €300M to part­ner up with In­novent on Chi­na mar­ket, eye­ing quick piv­ot to com­mer­cial­iza­tion

4 days ago

Premium storiesSee all

George Yan­copou­los says he's on the trail of the holy grail: ‘This could rep­re­sent the next break­through for ...

5 days ago
Bioregnum
Pharma

Gran­flu­encers and boom­flu­encers: Is the hip­ster old­ster so­cial me­dia trend mov­ing to phar­ma?

6 days ago
Pharma
Marketing

An MIT pro­fes­sor's rare dis­ease quest rip­ples through­out biotech

6 days ago
People
In Focus

Af­ter Roe, star­tups seek to fill Big Phar­ma’s male con­tra­cep­tion gap

Last week
Startups
In Focus

In FocusSee all

Af­ter abor­tion rul­ing, biotechs be­hind nov­el con­tra­cep­tives say tide is turn­ing on in­sur­ance cov­er­age

3 weeks ago

DNA se­quenc­ing gi­ant Il­lu­mi­na bat­tles an­titrust reg­u­la­tors and grow­ing com­pe­ti­tion

3 weeks ago
Pharma

How pre­pared is bio­phar­ma for the cy­ber dooms­day?

Last month
Pharma

A new era of treat­ment: How bio­mark­ers are chang­ing the way we think about can­cer

2 months ago
R&D

Don't missSee all

Karuna's schiz­o­phre­nia drug pass­es a close­ly-watched PhI­II test, will head to FDA in mid-2023

16 hours ago
R&D

UP­DAT­ED: In a fresh dis­ap­point­ment, Am­gen spot­lights a ma­jor safe­ty is­sue with KRAS com­bo

Yesterday
R&D
Pharma

A $5B Pfiz­er buy­out? Am­gen, Gilead head­line M&A Thurs­day; Al­ny­lam's AT­TR sweep; An­drew Lo's rare dis­ease quest; and ...

2 days ago
Weekly

AARP push­es for Medicare ne­go­ti­a­tions in TV ad as Con­gress tees up drug pric­ing leg­is­la­tion vote

3 days ago
Pharma
Marketing

Endpoints Standouts

Sci­en­tists are fi­nal­ly learn­ing how to de­sign pro­teins from scratch. Drug de­vel­op­ment may nev­er be the same

2 months ago
People
Discovery

The 20(+1) un­der 40: Your guide to the next gen­er­a­tion of biotech lead­ers

3 months ago
Special

The 2022 top 100 bio­phar­ma in­vestors: A look back on boom times

5 months ago
Financing
Deals

Spe­cial re­port: Meet 20 ex­tra­or­di­nary women who are su­per­charg­ing bio­phar­ma R&D

8 months ago
People
Special

Peer review See all

Aug
5

Astel­las taps sea­soned CMO amid shift to on­col­o­gy; Doug Man­ion steps in­to a new Are­na fol­low­ing $6.7B buy­out

Jul
29

For­mer eGe­n­e­sis CEO joins vTv as it tries to make a come­back; Ei­sai nabs Alzheimer’s com­mer­cial ex­ec amid lecanemab ...

Jul
22

Ex-Mod­er­na com­mer­cial leader lands at Cel­sion as CEO; Schwan song: Chang­ing of the guard at Roche to take ef­fect next ...

Jul
15

For­mer Spark ex­ec to lead a gene ther­a­py up­start of his own; Big Phar­ma mar­ket­ing vet named CEO of Swiss biotech

Jul
8

En­tos lures for­mer Plexxikon CEO to guide push to­ward the clin­ic; Ex-Bris­tol My­ers im­munol­o­gy chief finds new home

Pharma channel feed

5 days ago

Al­ny­lam her­alds PhI­II APOL­LO-B win on way to cre­at­ing an ‘in­dus­try lead­ing TTR fran­chise’

Al­ny­lam $AL­NY has laid claim to a ma­jor suc­cess in Phase III, with its RNAi drug patisir­an hit­ting the pri­ma­ry end­point in its APOL­LO-B study for AT­TR amy­loi­do­sis with car­diomy­opa­thy, one ...

READ MORE

Sen­ate Dems cling to a sim­ple ma­jor­i­ty to pass some of the biggest drug pric­ing re­forms ever

18 hours ago
Law

US de­clares mon­key­pox a na­tion­al health emer­gency, as new drug­mak­ers con­sid­er en­ter­ing vac­cine race

3 days ago
R&D
Manufacturing
latest in Pharma

Rea­ta con­tin­ues to hit FDA road­blocks with its Friedre­ich’s atax­ia can­di­date, not­ing reg­u­la­tor 'con­cern­s'

15 hours ago
R&D

As­traZeneca push­es for­ward with Tagris­so com­bos, tout­ing PhII da­ta with Hutchmed drug

18 hours ago
R&D

Bio­haven touts surge in Nurtec sales ahead of Pfiz­er takeover

3 days ago

De­moc­rats se­cure sup­port from key sen­a­tor ahead of po­ten­tial drug pric­ing vote

3 days ago
FDA+

Aca­dia hits an­oth­er Nu­plazid road­block as the FDA doles out CRL and rec­om­mends an­oth­er tri­al

3 days ago
FDA+
see latest stories

Marketing channel feed

3 days ago

Phar­ma brands chill in the phar­ma­cy re­tail aisle with new style ads on re­frig­er­a­tion screens

Want a pre­scrip­tion drug with that so­da? While not di­rect­ly pos­si­ble, ads for phar­ma brands now run­ning on bev­er­age and snack cool­er screens at phar­ma­cy re­tail­ers may at least in­spire ...

READ MORE

Drug pro­mo­tion en­force­ment so far sim­i­lar un­der new FDA chief, with just 4 let­ters in first half of 2022

5 days ago
Pharma
FDA+

Mar­ket­ingRx roundup: Bio­haven study links mi­graine and men­tal health; B+L bows Tik­Tok chal­lenge

6 days ago
Pharma
latest in Marketing

Am­gen diss­es drug pric­ing bill, while amp­ing $4B rare drug com­pa­ny deal and up­com­ing Hu­mi­ra biosim launch

3 days ago
Pharma

Bris­tol My­er­s' on­line ini­tia­tive ad­vo­cates work sup­port for MS pa­tients and care­givers

4 days ago
Pharma

Bio­gen's new SMA aware­ness cam­paign in Spain spot­lights the 'in­vis­i­ble' care­givers

Last week
Pharma

Ab­b­Vie, No­vo Nordisk TV ads gen­er­ate most search­es in first half of 2022, ad track­er finds

Last week
Pharma

Trans­plant Games kick off in San Diego, rais­ing or­gan do­na­tion aware­ness, com­mu­ni­ty and hope

Last week
Pharma
see latest stories

FDA+ channel feed

5 days ago

CDC, NIH, FDA lead­ers call for US-based clin­i­cal tri­al of small­pox drug in treat­ing mon­key­pox

With the ris­ing num­ber of mon­key­pox cas­es, lead­ing re­searchers at the CDC, FDA and NIH are call­ing on a ran­dom­ized clin­i­cal tri­al to see if an ap­proved small­pox drug is ef­fec­tive at ...

READ MORE

FDA is­sues new guid­ance for changes to dis­pos­able man­u­fac­tur­ing ma­te­ri­als

4 days ago
Manufacturing

Tra­vere fails to con­vince reg­u­la­tors to con­sid­er ac­cel­er­at­ed ap­proval for a rare kid­ney dis­ease — again

4 days ago
R&D
latest in FDA+

Co­herus pulls first in­ter­change­able biosim­i­lar win for Lu­cen­tis copy­cat

5 days ago
Pharma

UP­DAT­ED: J&J nabs la­bel ex­pan­sion for Ste­lara in pe­di­atric pso­ri­at­ic arthri­tis

Last week
Pharma

Celyad gets the go-ahead to re­sume CAR-T tri­al for col­orec­tal can­cer as FDA lifts hold

Last week
R&D

Not yet in the clin­ic, Beam’s base-edit­ed, off-the-shelf CAR-T put on hold

Last week
R&D
Cell/Gene Tx

Ar­cutis pulls in a win for its top­i­cal ver­sion of an old As­traZeneca drug in plaque pso­ri­a­sis

Last week
Pharma
see latest stories

Manufacturing channel feed

4 days ago

Man­u­fac­tur­ing roundup: So­ci­etal CD­MO nets new cus­tomers; Chime Bi­o­log­ics gets the OK to man­u­fac­ture an­ti­bod­ies

So­ci­etal CD­MO has been award­ed ser­vice con­tracts for three new cus­tomers. The agree­ments in­clude an ar­ray of man­u­fac­tur­ing ser­vices, for clin­i­cal tri­als, an­a­lyt­i­cal meth­ods, for­mu­la­tion ...

READ MORE

Ther­mo Fish­er com­pletes $76M cell cul­ture man­u­fac­tur­ing site near Buf­fa­lo, NY

4 days ago

Green­Light Bio­sciences cel­e­brates man­u­fac­tur­ing mile­stone for Covid-19 boost­er can­di­date

4 days ago
Pharma
Coronavirus
latest in Manufacturing

Two CD­MOs come to­geth­er as they look to ex­pand their reach in cell ther­a­py man­u­fac­tur­ing

4 days ago
Deals
Cell/Gene Tx

As a hand­ful of com­pa­nies spin out health busi­ness­es, Ger­many's Schott glass­mak­er looks to get in on the ac­tion

5 days ago

Gene ther­a­py biotech us­es its man­u­fac­tur­ing sites as col­lat­er­al to net a $100M loan

5 days ago
Financing
Cell/Gene Tx

Cu­ria nets con­tract for cannabi­noid can­di­date and taps a new pres­i­dent of man­u­fac­tur­ing

6 days ago
People
Pharma

3M plans to spin out $8.5B health­care di­vi­sion in­to its own com­pa­ny

6 days ago
see latest stories